Does the Type of Prosthesis Influence the Incidence of Permanent Pacemaker Implantation Following Isolated Aortic Valve Replacement
Background: The incidence of conduction disorders requiring permanent pacing (PPM) in patients operated on for aortic valve replacement (AVR) has been reported to be 5.7%. However, perioperative risk predictors for PPM following AVR are not well characterized and debate exists regarding selection of the prosthesis-type most likely to minimize this incidence. The aim of the study was to assess whether the type of the prosthesis used influences the prevalence of PPM following aortic valve replacement.
Methods: A total of 782 consecutive patients with predominant aortic stenosis accepted for isolated non-emergent AVR were studied over a 3 year period; of which 305 patients (Group A) received mechanical prostheses, 335 received stented tissue prostheses (Group B), and the remaining 142 received stentless tissue valves (Group C). A stepwise logistic regression analysis was used to identify the independent predictors for PPM and statistical significance was accepted at a level of P < .05.
Results: Univariate and multivariate analyses showed a significant relationship between the preoperative factors (poor ejection fraction <35%; P < .001), left atrial enlargement (LAE; P < .001) and left bundle branch block (LBBB; P < .001), the perioperative variables (bypass time >100 minutes with x-clamp time >70 minutes; P < .001) and the incidence of PPM.
Conclusions: The proposed predictive model correlated highly with actual pacemaker use, suggesting that the requirement for PPM results from either operative trauma or increased ischemic burden and the incidence of PPM is independent of prosthesis-type implanted.
Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. 2003. Impact of valve prosthesis-patient mismatch on short term mortality after aortic valve replacement. Circulation 108:983-8.nBoughaleb D, Mansourati J, Genet L, Barra J, Mondine P, Blanc JJ. 1994. Permanent cardiac stimulation after aortic valve replacement: incidence, predictive factors and long-term prognosis. Arch Mal Coeur Vaiss 87:925-30.nBraunwald E. 2000. Aortic valve replacement; an update at the turn of the millennium. Eur J Heart 21:1032-3.nBreisch EA, White FC, Bloor CM. 1984. Myocardial characteristics of pressure overload hypertrophy. A structural and functional study. Lab Invest 51:333-42.nDel Rizzo DF, Nishimura S, Lau C, Sever J, Goldman BS. 1996. Cardiac pacing following surgery for acquired heart disease. J Cardiovasc Surg 11:332-40.nGerber IL, Stewart RA, Hammett CJ, et al. 2003. Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol 92:1129-32.nGordon RS, Ivanov J, Cohen G, Ralph-Edwards AL. 1998. Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers. Ann Thorac Surg 66:1698-704.nJalil JE, Doering CW, Janicki JS, et al. 1989. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64:1041-50.nKeefe DL, Griffin JC, Harrison DC, Stinson EB. 1985. Atrioventricular conduction abnormalities in patients undergoing isolated aortic or mitral valve replacement. Pacing Clin Electrophysiol 8:393-8.nPfeiffer MA, Braunwald E. 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161-72.nSia YT, Lapointe N, Parker TG, et al. 2002. Beneficial effects of long-term use of the antioxidant probucol in heart failure in rat. Circulation 105:2549-55.nVerdecchia P, Schillaci C, Borgoni C, et al. 1998. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 273:2161-8.nGoldman BS, David TE, Del Rizzo DF, Sever J, Bos J. 1994. Stentless porcine bioprosthesis for aortic valve replacement. J Cardiovasc Surg 35:105-10.nLimongelli G, Ducceschi V, D'Andrea A, et al. 2003. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart 89:901-4.nMorisco C, Sadoshima J, Trimarco B, Arora R, Vatner DE, Vatner SF. 2003. Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus. Am J Physiol Heart Circ Physiol 284:H1043-7.nMuiesan ML, Salvetti M, Rizoni D, Castellano M, Donato F, Agabiti-Rosei E. 1995. Association of change in left ventricular mass with prognosis during long-term anti-hypertensive treatment. J Hypertens 13:1091-5.nElahi MM, Lee D, Bhandari M, Dhannapuneni RV, Sosnowski AW. 2005. Permanent pacemaker implantation after valve surgery: assessing its need in early postoperative period: our experience in a tertiary centre. Br J Cardiol (in press).nKvidal P, Bergstorm R, Malm T, et al. 2000. Long term follow up of morbidity and mortality after aortic valve replacement with mechanical valve prostheses. Eur Heart J 21:1099-111.nLewis JW Jr, Webb CR, Pickard SD, Lehman J, Jacobsen G. 1998. The increased need for a permanent pacemaker after reoperative cardiac surgery. J Thorac Cardiovasc Surg 116:74-81.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).